Skip to main content
GutCited

Butyrate (Sodium/Calcium Butyrate) için Ulcerative Colitis (UC)

C

Recent 90-day RCT (140 IBD participants) showed oral butyrate improved Crohn's symptoms and QoL. Earlier studies on butyrate enemas showed benefit in distal UC.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbutyrate\u0026condition\u003Dibd\u002Dulcerative\u002Dcolitis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Sonuç

Recent 90-day RCT (140 IBD participants) showed oral butyrate improved Crohn's symptoms and QoL. Earlier studies on butyrate enemas showed benefit in distal UC.

Key Study Findings

Randomized Controlled Trial n=140 Double-blind
Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study …
Dose: None vs: placebo plus conventional therapy Outcome: clinical disease activity and fecal calprotectin Etki: None p=0.013

Popülasyon: IBD patients (60 Crohn's disease, 80 ulcerative colitis)

basic science
Lactobacillus reuteri E9 Regulates Sleep Disorders Through Its Metabolite GABA.
Dose: Lactobacillus reuteri E9 (dose not specified) vs: Placebo Etki: None < 0.05
In Vitro
Sea buckthorn berries alleviate ulcerative colitis via regulating gut Faecalibaculum rodentium-mediated butyrate biosynthesis.
Dose: None vs: DSS-induced UC mice model Outcome: UC symptom alleviation via gut microbiota Etki: None p<0.05

Popülasyon: DSS-induced UC murine model

In Vitro
Gut microbiota-derived butyrate mediates the anticolitic effect of indigo supplementation through regulating CD4+ T cell …
Dose: None vs: UC animal and clinical samples Outcome: Intestinal inflammation via CD4+ T cell regulation Etki: None None

Popülasyon: UC murine model + UC patient samples

Randomized Controlled Trial n=36 12 weeks Double-blind
Effects of Short Chain Fatty Acid-Butyrate Supplementation on the Disease Severity, Inflammation, and Psychological Factors …
Dose: 600 mg/kg with main meal vs: Placebo (rice starch) Outcome: Mayo score, ESR, anxiety/depression (HADS) Etki: Mayo score -2.33 vs +0.22 p<0.001 (Mayo, dep, GHQ)

Popülasyon: Active ulcerative colitis patients

In Vitro
Sodium butyrate regulates macrophage polarization by TGR5/β-arrestin2 in vitro.
Dose: None vs: LPS-stimulated RAW264.7 cells Outcome: Macrophage polarization (M1 to M2 shift) Etki: None None

Popülasyon: RAW264.7 macrophage cell line

Key Statistics

3

Çalışmalar

390

Katılımcılar

Positive

C

Derece

Referenced Papers

Langenbeck's archives of … 2025 3 atıf
Nutrients 2023 9 atıf
Current pharmaceutical design 2018 108 atıf
Comprehensive Physiology 2017 245 atıf
Journal of AOAC … 2004
Current opinion in … 2000 28 atıf
Digestive diseases and … 1997 254 atıf
Bailliere's clinical gastroenterology 1997 26 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
150-600 mg/day sodium or calcium butyrate
ibdsupport:
300-600 mg three times daily (900-1,800 mg/day)
butyrateenema:
100 mM butyrate enema for distal UC (clinical setting only)

Üst sınır: No established upper limit for oral supplements; most studies use 600-4,000 mg/day

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Positive 140
Lactobacillus reuteri E9 (dose not specified) -- Positive --
None -- Positive --
None -- Positive --
600 mg/kg with main meal 12 weeks Positive 36
None -- Positive --
5 mg/mL -- Positive --
None -- Positive --

En iyi alım zamanı: With meals; enteric-coated formulations recommended to reach the colon

Safety & Side Effects

Bildirilen Yan Etkiler

  • Unpleasant taste/odor (butyric acid has a strong rancid butter smell)
  • Mild GI discomfort (nausea, bloating)
  • Belching with butyric acid odor
  • Enteric-coated formulations reduce taste issues

Bilinen Etkileşimler

  • 5-ASA medications (mesalamine) — additive anti-inflammatory effect (potentially beneficial in IBD)
  • No significant adverse drug interactions known

Tolere edilebilir üst alım: No established upper limit for oral supplements; most studies use 600-4,000 mg/day

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Butyrate (Sodium/Calcium Butyrate) help with Ulcerative Colitis (UC)?
Based on 3 studies with 390 participants, there is limited but promising evidence that Butyrate (Sodium/Calcium Butyrate) may support Ulcerative Colitis (UC) management. Our evidence grade is C (Some Evidence).
How much Butyrate (Sodium/Calcium Butyrate) should I take for Ulcerative Colitis (UC)?
Studies have used various dosages. A commonly studied range is 150-600 mg/day sodium or calcium butyrate. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Butyrate (Sodium/Calcium Butyrate)?
Reported side effects may include Unpleasant taste/odor (butyric acid has a strong rancid butter smell), Mild GI discomfort (nausea, bloating), Belching with butyric acid odor, Enteric-coated formulations reduce taste issues. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Butyrate (Sodium/Calcium Butyrate) and Ulcerative Colitis (UC)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 3 peer-reviewed studies with 390 total participants. The overall direction of effect is positive.

Related Evidence

Butyrate (Sodium/Calcium Butyrate) diğer sağlık durumları için

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.